U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07490340) titled 'Trans-Oral Sampling as an Alternative Surveillance of Barrett's Esophagus Pilot' on Oct. 12, 2023.
Brief Summary: The study aims to address the increasing incidence of esophageal cancer and Barrett's esophagus (BE) in the Western world by exploring a more efficient surveillance method. Esophageal adenocarcinoma (EAC) has a poor prognosis if diagnosed late, emphasizing the need for early detection strategies. Current surveillance methods, involving regular endoscopies, are burdensome and costly, particularly for low-risk patients. The study investigates the potential of the Endosign, a Trans Oral Sampling (TOS) device, as an alterna...